(Q38942597)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25371409%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

Four-in-one antibodies have superior cancer inhibitory activity against EGFR, HER2, HER3, and VEGF through disruption of HER/MET crosstalk (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25371409%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25371409%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Wenyan Fu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25371409%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Weihao Xu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25371409%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Yang Yang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25371409%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Melissa Cruz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25371409%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Sandra D Berezov

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25371409%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Daniel Jorissen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25371409%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Hiroaki Takeda

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25371409%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Wangdong Zhu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25371409%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

language of work or name

English

0 references

publication date

4 November 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25371409%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25371409%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

75

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25371409%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25371409%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

159-170

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25371409%20AND%20SRC:MED&resulttype=core&format=json

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

22 February 2020

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.1141478

Identifiers

DOI

10.1158/0008-5472.CAN-14-1670

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25371409%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference